The future of minimally invasive cancer treatment is today.
Quantum Surgical presents Epione®, a state-of-the art robotic-assisted platform designed to transform interventional oncology.

The Epione robotic-assisted percutaneous ablation platform
The Epione® robotic-assisted platform supports interventional radiologists in treating inoperable or challenging early-staged tumors, due to their size, shape or location, without any surgical intervention.
This cutting-edge technology guides physicians to perform safe and effective percutaneous tumor ablation, a minimally invasive treatment in which one or multiple needles are inserted through the skin to destroy the tumor.
Percutaneous ablation is underutilized as a first-line treatment for cancer patients due to procedural workflow limitations and complexities. Epione is designed to overcome these challenges.

Why ablation for tumor treatment?
How does the Epione robot work?
Who is successfully using Epione?
Epione® by the numbers
Patients treated worldwide
Cancer center installations
Patents
Market approvals
Indications*
* Epione device is CE marked for abdomen and lung indications, and FDA cleared for abdominal ablation indication. CE mark for bone indication extension ongoing.
Epione user testimonials
The technical difficulty involved in placing the needle (or needles) is reduced, and I can focus on patient safety and the oncological efficacy of tumour destruction.

The needles are placed exactly where we predicted they would be. With the human hand, the needles are approximately where we predicted

With Epione, you just have to identify the volume of the tumor, click on the center of it, and pick the number of needles that you’re going to use. It gives you a trajectory for all needles that you’re going to place. Everything is done with one click, so it saves a significant amount of time.

[Epione] will enable us to push back the boundaries. These treatments are confined to very expert hands, and the idea behind it is to be able to democratize these treatments and give access to these minimally invasive technologies, to as many patients as possible.

[Epione] makes it possible to target very small or poorly placed tumors that were previously almost inaccessible. Around 20% of the 70 people we have already operated would not have been possible before.

Latest news
Where to find Epione
Questions? Answers.
Browse the FAQ,.
If you can't find the answer to your question, please contact us.
Quantum Surgical is a French company specializing in medical robotics and AI, co-founded in 2017 by Bertin Nahum, CEO.
With a dynamic team of over 130 employees, the company is headquartered in Montpellier, France, and has offices in Miami, Florida. Its Epione platform is dedicated to the curative and early treatment of cancers.
Quantum Surgical offers a new approach to cancer treatment by standardizing access to care. More patients can benefit from innovative, better-targeted, and less invasive treatments. Hundreds of patients have already been treated worldwide.
Percutaneous ablation is a technique part of interventional oncology and an alternative to surgery. It involves the insertion of a thin needle or probe through the skin (percutaneously) and into the targeted area to destroy or remove the tumor. It makes it possible to treat tumors that are particularly difficult to reach, due to their size or their location.
Percutaneous ablation is an alternative to surgery and can offer many benefits to patients:
• Tumor can be treated at a very early stage
• Treatment is better targeted and therefore leads to minimal damage to healthy tissues surrounding the tumor
• Treatment is less invasive, thus more comfortable
• Pain is reduced- Recovery time is shorter for patients- Possibility of outpatient procedure
Read more
While significant progress has been made in recent years in the prevention, detection, and diagnosis of cancer, the field of curative treatment remains an area of high expectations for innovations. Quantum Surgical's flagship product, the Epione® robotic platform, is specifically dedicated to the curative and early treatment of cancers. Epione® is a robotic-assisted percutaneous ablation system, using a robotic arm, a navigation system and a camera.
This procedure is an alternative to surgery and makes it possible to treat tumors that are particularly difficult to reach, due to their size or their location. Relying on the know-how of the physician, Epione® integrates all the steps of a percutaneous ablation procedure in a single platform: planning, targeting, ablation, confirmation.
Beyond the new therapeutic response it provides, Epione® makes it possible to offer patients a minimally invasive treatment, which improves their comfort and facilitates their recovery.
For physicians and hospitals, Epione provides gesture security and promotes the standardization of minimally invasive tumor removal procedures, a major challenge given that more than 4 million abdominal and lung cancers are diagnosed worldwide every year (source: Globocan).
Patients can be treated with Epione in Europe and in the United States:
• Gustave Roussy (Villejuif, France),
• Hospices Civils de Lyon (Lyon, France)
• Institut Paoli-Calmettes (Marseille France)
• CHU Amiens-Picardie (Amiens, France)
• CHU de Toulouse (France)
• Baptist Health South Florida (Miami, Florida)
• Rush University System for Health (Chicago, Illinois)
New installations will take place in Europe and the United States in the coming weeks.
2. TÜV Rheinland (August 31, 2021). MDR Ann. IX, Chapt I Certificate (Certificate No. HZ 1551912-1). Quantum Surgical SAS. [https://www.certipedia.com/certificates/HZ+1551912-1].